{"id":953,"date":"2014-10-24T00:00:00","date_gmt":"2022-03-10T02:46:50","guid":{"rendered":"https:\/\/www.lrmm.com\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/"},"modified":"2022-03-10T00:21:53","modified_gmt":"2022-03-10T05:21:53","slug":"guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp","status":"publish","type":"post","link":"https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/","title":{"rendered":"Guy Dancosse &#8211; Membre du conseil d\u2019administration de Abattis Bioceuticals Corp"},"content":{"rendered":"<p> Guy Dancosse a \u00e9t\u00e9 nomm\u00e9 membre du conseil d\u2019administration de l\u2019entreprise Abattis Bioceuticals Corp.<\/p>\n<p>Abattis est une soci\u00e9t\u00e9 sp\u00e9cialis\u00e9e en biotechnologie qui, gr\u00e2ce \u00e0 ses filiales en propri\u00e9t\u00e9 exclusive, peut, d\u2019une part, cultiver et commercialiser des ingr\u00e9dients exclusifs et des compos\u00e9s biologiques ult\u00e9rieurs et accorder des licences sur ceux-ci, et d\u2019autre part, commercialiser de l\u2019\u00e9quipement brevet\u00e9 et offrir des services consultatifs sur les march\u00e9s m\u00e9dicinaux nord-am\u00e9ricains.<\/p>\n<p>En approvisionnant les entreprises et en collaborant avec elles pour l\u2019utilisation de ses syst\u00e8mes de culture verticale, de sa technologie et de son mat\u00e9riel d\u2019extraction et de son programme d\u2019aide \u00e0 la mise en march\u00e9 destin\u00e9 aux cultivateurs autoris\u00e9s, la soci\u00e9t\u00e9 est bien positionn\u00e9e pour profiter de la tendance prononc\u00e9e vers la l\u00e9galisation de la marijuana aux \u00c9tats-Unis et l\u2019utilisation de celle-ci \u00e0 des fins m\u00e9dicales au Canada et dans les territoires internationaux.<\/p>\n<p>En outre, la soci\u00e9t\u00e9 poss\u00e8de une large gamme de produits de haute qualit\u00e9 de m\u00eame que des droits de propri\u00e9t\u00e9 intellectuelle adapt\u00e9s au march\u00e9 en pleine expansion des m\u00e9dicaments botaniques. Nous nous conformons rigoureusement aux protocoles op\u00e9rationnels normalis\u00e9s et aux lois du Canada et des territoires \u00e9trangers.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Guy Dancosse a \u00e9t\u00e9 nomm\u00e9 membre du conseil d\u2019administration de l\u2019entreprise Abattis Bioceuticals Corp. Abattis est une soci\u00e9t\u00e9 sp\u00e9cialis\u00e9e en biotechnologie qui, gr\u00e2ce \u00e0 ses filiales en propri\u00e9t\u00e9 exclusive, peut, d\u2019une part, cultiver et commercialiser des ingr\u00e9dients exclusifs et des compos\u00e9s biologiques ult\u00e9rieurs et accorder des licences sur ceux-ci, et d\u2019autre part, commercialiser de l\u2019\u00e9quipement [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49,27,44],"tags":[],"class_list":["post-953","post","type-post","status-publish","format-standard","hentry","category-2014-nouvelles","category-actualite-s","category-nouvelles"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Guy Dancosse - Membre du conseil d\u2019administration de Abattis Bioceuticals Corp - Lapointe Rosenstein Marchand Melan\u00e7on<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Guy Dancosse - Membre du conseil d\u2019administration de Abattis Bioceuticals Corp - Lapointe Rosenstein Marchand Melan\u00e7on\" \/>\n<meta property=\"og:description\" content=\"Guy Dancosse a \u00e9t\u00e9 nomm\u00e9 membre du conseil d\u2019administration de l\u2019entreprise Abattis Bioceuticals Corp. Abattis est une soci\u00e9t\u00e9 sp\u00e9cialis\u00e9e en biotechnologie qui, gr\u00e2ce \u00e0 ses filiales en propri\u00e9t\u00e9 exclusive, peut, d\u2019une part, cultiver et commercialiser des ingr\u00e9dients exclusifs et des compos\u00e9s biologiques ult\u00e9rieurs et accorder des licences sur ceux-ci, et d\u2019autre part, commercialiser de l\u2019\u00e9quipement [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/\" \/>\n<meta property=\"og:site_name\" content=\"Lapointe Rosenstein Marchand Melan\u00e7on\" \/>\n<meta property=\"article:published_time\" content=\"2022-03-10T02:46:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-10T05:21:53+00:00\" \/>\n<meta name=\"author\" content=\"mlbwdev\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"mlbwdev\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/\"},\"author\":{\"name\":\"mlbwdev\",\"@id\":\"https:\/\/www.lrmm.com\/fr\/#\/schema\/person\/a494b773bde4003555adf65ea3a908b2\"},\"headline\":\"Guy Dancosse &#8211; Membre du conseil d\u2019administration de Abattis Bioceuticals Corp\",\"datePublished\":\"2022-03-10T02:46:50+00:00\",\"dateModified\":\"2022-03-10T05:21:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/\"},\"wordCount\":231,\"commentCount\":0,\"articleSection\":[\"2014\",\"Actualit\u00e9s\",\"Nouvelles\"],\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/\",\"url\":\"https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/\",\"name\":\"Guy Dancosse - Membre du conseil d\u2019administration de Abattis Bioceuticals Corp - Lapointe Rosenstein Marchand Melan\u00e7on\",\"isPartOf\":{\"@id\":\"https:\/\/www.lrmm.com\/fr\/#website\"},\"datePublished\":\"2022-03-10T02:46:50+00:00\",\"dateModified\":\"2022-03-10T05:21:53+00:00\",\"author\":{\"@id\":\"https:\/\/www.lrmm.com\/fr\/#\/schema\/person\/a494b773bde4003555adf65ea3a908b2\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.lrmm.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Guy Dancosse &#8211; Membre du conseil d\u2019administration de Abattis Bioceuticals Corp\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.lrmm.com\/fr\/#website\",\"url\":\"https:\/\/www.lrmm.com\/fr\/\",\"name\":\"Lapointe Rosenstein Marchand Melan\u00e7on\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.lrmm.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.lrmm.com\/fr\/#\/schema\/person\/a494b773bde4003555adf65ea3a908b2\",\"name\":\"mlbwdev\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.lrmm.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/8ac5052f5b8214925aa49a0e82e9cfb1105700e37a07755ea489abcaad17c9d9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/8ac5052f5b8214925aa49a0e82e9cfb1105700e37a07755ea489abcaad17c9d9?s=96&d=mm&r=g\",\"caption\":\"mlbwdev\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Guy Dancosse - Membre du conseil d\u2019administration de Abattis Bioceuticals Corp - Lapointe Rosenstein Marchand Melan\u00e7on","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/","og_locale":"fr_CA","og_type":"article","og_title":"Guy Dancosse - Membre du conseil d\u2019administration de Abattis Bioceuticals Corp - Lapointe Rosenstein Marchand Melan\u00e7on","og_description":"Guy Dancosse a \u00e9t\u00e9 nomm\u00e9 membre du conseil d\u2019administration de l\u2019entreprise Abattis Bioceuticals Corp. Abattis est une soci\u00e9t\u00e9 sp\u00e9cialis\u00e9e en biotechnologie qui, gr\u00e2ce \u00e0 ses filiales en propri\u00e9t\u00e9 exclusive, peut, d\u2019une part, cultiver et commercialiser des ingr\u00e9dients exclusifs et des compos\u00e9s biologiques ult\u00e9rieurs et accorder des licences sur ceux-ci, et d\u2019autre part, commercialiser de l\u2019\u00e9quipement [&hellip;]","og_url":"https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/","og_site_name":"Lapointe Rosenstein Marchand Melan\u00e7on","article_published_time":"2022-03-10T02:46:50+00:00","article_modified_time":"2022-03-10T05:21:53+00:00","author":"mlbwdev","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"mlbwdev","Estimation du temps de lecture":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/#article","isPartOf":{"@id":"https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/"},"author":{"name":"mlbwdev","@id":"https:\/\/www.lrmm.com\/fr\/#\/schema\/person\/a494b773bde4003555adf65ea3a908b2"},"headline":"Guy Dancosse &#8211; Membre du conseil d\u2019administration de Abattis Bioceuticals Corp","datePublished":"2022-03-10T02:46:50+00:00","dateModified":"2022-03-10T05:21:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/"},"wordCount":231,"commentCount":0,"articleSection":["2014","Actualit\u00e9s","Nouvelles"],"inLanguage":"fr-CA","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/","url":"https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/","name":"Guy Dancosse - Membre du conseil d\u2019administration de Abattis Bioceuticals Corp - Lapointe Rosenstein Marchand Melan\u00e7on","isPartOf":{"@id":"https:\/\/www.lrmm.com\/fr\/#website"},"datePublished":"2022-03-10T02:46:50+00:00","dateModified":"2022-03-10T05:21:53+00:00","author":{"@id":"https:\/\/www.lrmm.com\/fr\/#\/schema\/person\/a494b773bde4003555adf65ea3a908b2"},"breadcrumb":{"@id":"https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.lrmm.com\/fr\/actualite-s\/nouvelles\/2014-nouvelles\/guy-dancosse-membre-du-conseil-dadministration-de-abattis-bioceuticals-corp\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.lrmm.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Guy Dancosse &#8211; Membre du conseil d\u2019administration de Abattis Bioceuticals Corp"}]},{"@type":"WebSite","@id":"https:\/\/www.lrmm.com\/fr\/#website","url":"https:\/\/www.lrmm.com\/fr\/","name":"Lapointe Rosenstein Marchand Melan\u00e7on","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lrmm.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Person","@id":"https:\/\/www.lrmm.com\/fr\/#\/schema\/person\/a494b773bde4003555adf65ea3a908b2","name":"mlbwdev","image":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.lrmm.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/8ac5052f5b8214925aa49a0e82e9cfb1105700e37a07755ea489abcaad17c9d9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8ac5052f5b8214925aa49a0e82e9cfb1105700e37a07755ea489abcaad17c9d9?s=96&d=mm&r=g","caption":"mlbwdev"}}]}},"_links":{"self":[{"href":"https:\/\/www.lrmm.com\/fr\/wp-json\/wp\/v2\/posts\/953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lrmm.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lrmm.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lrmm.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lrmm.com\/fr\/wp-json\/wp\/v2\/comments?post=953"}],"version-history":[{"count":0,"href":"https:\/\/www.lrmm.com\/fr\/wp-json\/wp\/v2\/posts\/953\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.lrmm.com\/fr\/wp-json\/wp\/v2\/media?parent=953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lrmm.com\/fr\/wp-json\/wp\/v2\/categories?post=953"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lrmm.com\/fr\/wp-json\/wp\/v2\/tags?post=953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}